| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 53.74M | -18.82M | 70.23M | 94.28M | -3.16B |
| Gross Profit | 38.78M | -18.82M | 36.89M | 63.22M | -3.19B |
| EBITDA | 191.06M | -102.88M | -2.62M | -69.05M | -3.49B |
| Net Income | 179.05M | -194.51M | -84.49M | -81.09M | -3.15B |
Balance Sheet | |||||
| Total Assets | 3.29B | 3.22B | 3.89B | 5.75B | 6.31B |
| Cash, Cash Equivalents and Short-Term Investments | 576.79M | 282.37M | 622.85M | 759.13M | 1.57B |
| Total Debt | 57.05M | 59.80M | 63.23M | 301.51M | 257.21M |
| Total Liabilities | 167.60M | 181.63M | 157.34M | 475.82M | 570.81M |
| Stockholders Equity | 3.11B | 3.03B | 3.73B | 5.28B | 5.74B |
Cash Flow | |||||
| Free Cash Flow | -210.41M | -317.33M | 344.59M | 659.68M | -3.05B |
| Operating Cash Flow | -210.40M | -317.25M | 350.43M | 673.38M | -3.05B |
| Investing Cash Flow | 338.94M | 242.20M | -243.83M | -964.48M | -314.95M |
| Financing Cash Flow | -11.70M | -4.33M | -125.71M | 28.90M | -11.25M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$1.92B | 9.33 | 0.89% | 3.28% | 9.64% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | HK$13.82B | 25.90 | 5.69% | ― | 35.59% | ― | |
58 Neutral | HK$1.72B | 18.39 | 1.63% | 2.14% | -20.02% | 10.62% | |
47 Neutral | HK$860.42M | -3.89 | -14.53% | ― | -57.15% | -223.53% | |
41 Neutral | HK$914.51M | -1.60 | 21.05% | ― | -56.73% | -79.40% |